GUIDA, GIUSEPPE ANDREA
 Distribuzione geografica
Continente #
NA - Nord America 111
EU - Europa 81
AS - Asia 14
Totale 206
Nazione #
US - Stati Uniti d'America 111
IE - Irlanda 47
CN - Cina 14
IT - Italia 11
FI - Finlandia 7
DE - Germania 6
UA - Ucraina 5
CZ - Repubblica Ceca 3
SE - Svezia 2
Totale 206
Città #
Dublin 47
Chandler 29
Ashburn 17
New York 10
Shanghai 9
Helsinki 7
Lawrence 6
Medford 6
Princeton 6
Pavia 4
Beijing 3
Chicago 3
Novara 3
Olomouc 3
Washington 3
Boardman 2
Dearborn 2
Lissone 2
Los Angeles 2
Norwalk 2
Cedar Knolls 1
Guangzhou 1
Hefei 1
Munich 1
Pognana Lario 1
Redmond 1
Rockville 1
Wilmington 1
Woodbridge 1
Totale 175
Nome #
Prevalence and impact of COVID-19 sequelae on treatment and survival of patients with cancer who recovered from SARS-CoV-2 infection: evidence from the OnCovid retrospective, multicentre registry study 39
Risk of acute arterial and venous thromboembolic events in Eosinophilic Granulomatosis with Polyangiitis (Churg-Strauss syndrome) 37
Time-Dependent COVID-19 Mortality in Patients with Cancer: An Updated Analysis of the OnCovid Registry 36
COVID-19 in breast cancer patients: a subanalysis of the OnCovid registry 36
Retrospective analysis on safety and efficacy of everolimus in treatment of metastatic renal cancer patients receiving dialysis 28
The Tumor Entity Denominated “clear cell-papillary renal cell carcinoma” According to the WHO 2016 new Classification, have the Clinical Characters of a Renal Cell Adenoma as does Harbor a Benign Outcome 25
Time-Dependent COVID-19 Mortality in Patients with Cancer: An Updated Analysis of the OnCovid Registry 15
Totale 216
Categoria #
all - tutte 1.196
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.196


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20208 0 0 0 0 0 0 2 3 0 1 2 0
2020/20216 0 0 0 0 0 0 0 1 0 5 0 0
2021/202232 0 0 0 0 0 1 6 1 0 8 4 12
2022/2023105 11 9 4 5 6 9 0 1 50 0 9 1
2023/202462 8 6 4 1 1 26 5 1 0 2 4 4
2024/20253 3 0 0 0 0 0 0 0 0 0 0 0
Totale 216